Success Metrics

Completion Rate
0%(0/3)
Active Trials
0(0%)
Terminated
3(100%)

Phase Distribution

Ph phase_2
1
33%
Ph phase_3
2
67%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(3)

Detailed Status

Terminated3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (33.3%)
Phase 32 (66.7%)

Trials by Status

terminated3100%

Recent Activity

0 active trials
Showing 3 of 3
terminatedphase_2

A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging

NCT00162071
terminatedphase_3

A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress.

NCT00380198
terminatedphase_3

A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography

NCT00162084

Clinical Trials (3)

Showing 3 of 3 trials
NCT00162071Phase 2

A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging

Terminated
NCT00380198Phase 3

A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress.

Terminated
NCT00162084Phase 3

A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3